Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1337
| Despition | Neurochondrin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1847 | Human GFRA3 Protein (AC1847) | 5 µg | inquiry |
| ACPP-1376 | Mouse S100A5 Protein (AC1376) | 5 µg | inquiry |
| ACPP-1089 | Human GDF11 Protein (AC1089) | 5 µg | inquiry |
| ACPP-1770 | Human AHSG Protein (AC1770) | 2 µg | inquiry |
| ACPP-1011 | Recombinant Human FGF1 Protein (AC1011) | 50 µg | inquiry |
| ACPP-1122 | Synthetic Membrane Nanoparticle Human Adenosine Receptor A2a Protein (AC1122) | 50 µg | inquiry |
| ACPP-1021 | Recombinant Human PGP9.5 Protein (Fc Tag) (AC1021) | 50 µg | inquiry |
| ACPP-1741 | Human NDRG1 Protein (AC1741) | 10 µg | inquiry |
| ACPP-1226 | PDE7A Blocking Peptide (AC1226) | 250 µg | inquiry |
| ACPP-1560 | Human RBM17 Protein (AC1560) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.